Julie Miller, M.D., PH.D

Julie Miller, M.D., Ph.D., is a neurologist and neuro-oncologist at Massachusetts General Hospital in Boston, specializing in brain tumors, including gliomas and neuroblastoma. Her clinical expertise is complemented by extensive research into cancer metabolism and innovative therapeutic approaches, including PARP inhibitors and histone deacetylase inhibitors, aimed at improving treatment outcomes for patients with central nervous system malignancies. With over 200 peer-reviewed publications and